Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

10.32
+0.15001.47%
Post-market: 10.18-0.1400-1.36%19:30 EDT
Volume:1.89M
Turnover:19.29M
Market Cap:880.43M
PE:-5.91
High:10.38
Open:10.04
Low:9.82
Close:10.17
52wk High:25.77
52wk Low:7.44
Shares:85.31M
Float Shares:54.48M
Volume Ratio:0.95
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7450
EPS(LYR):-0.4650
ROE:-42.66%
ROA:-21.63%
PB:1.81
PE(LYR):-22.19

Loading ...

May 11, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 08, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence